# d-Serine’s Journey Between Stars and Synapses

**Authors:** Sarah Mountadem, Stéphane Henri Richard Oliet, Aude Panatier

PMC · DOI: 10.1007/s11064-025-04564-y · Neurochemical Research · 2025-10-14

## TL;DR

This review explores how astrocytes release d-serine, a molecule that influences brain functions like memory and may be linked to diseases like Alzheimer's.

## Contribution

The paper presents new insights into how astrocytic d-serine regulates synaptic plasticity and cognitive functions based on two decades of research.

## Key findings

- Astrocytic d-serine regulates NMDAR activity and long-term synaptic plasticity.
- Impairment in astrocytic d-serine synthesis may impact cognitive functions in Alzheimer's Disease.
- Astrocytic morphological plasticity and intracellular Ca2+ influence d-serine availability.

## Abstract

Astrocytes play a pivotal role in regulating synaptic transmission, with d-serine emerging as a key gliotransmitter shaping NMDA receptor-dependent functions. This review is focusing on the multifaceted role of astrocytic d-serine from synaptic transmission to cognitive processes. While this review includes the work of other groups, it is mainly based on the findings obtained in our laboratory. Drawing from two decades of research spanning from the hypothalamus to the hippocampus, we here highlight how astrocyte-derived d-serine regulates NMDAR activity, long-term synaptic plasticity, and associated memory. Our findings have revealed the dynamic control exerted by astrocytic processes onto d-serine availability within the synaptic cleft, including the impact of the astrocytic morphological plasticity, the key role played by intracellular Ca2+ as well as the involvement of CB1 and EphB3 receptors. We also discuss how an impairment in astrocytic d-serine synthesis can affect the co-agonist availability and consequently impact cognitive functions in neurodegenerative disorders such as Alzheimer’s Disease. To conclude, this review highlights the role of astrocytic d-serine in astrocyte-neuron communication and higher-order brain functions.

## Linked entities

- **Proteins:** Grin1 (glutamate receptor, ionotropic, NMDA1 (zeta 1)), CNR1 (cannabinoid receptor 1), EPHB3 (EPH receptor B3)
- **Chemicals:** d-serine (PubChem CID 71077), Ca2+ (PubChem CID 271)
- **Diseases:** Alzheimer’s Disease (MONDO:0004975)

## Full-text entities

- **Genes:** CNR1 (cannabinoid receptor 1) [NCBI Gene 1268] {aka CANN6, CB-R, CB1, CB1A, CB1K5, CB1R}, EPHB3 (EPH receptor B3) [NCBI Gene 2049] {aka EK2, ETK2, HEK2, TYRO6}
- **Diseases:** Alzheimer's Disease (MESH:D000544), neurodegenerative disorders (MESH:D019636)
- **Chemicals:** Ca2+ (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12521327/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12521327/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12521327/full.md

---
Source: https://tomesphere.com/paper/PMC12521327